Novartis Institute For Biomedical Research

What Novartis Institute For Biomedical Research does

The Novartis Institute For Biomedical Research is a biomedical research entity affiliated with Novartis AG, a global pharmaceutical company, as indicated by its naming convention. Firmographic data places the institute in Emeryville, California, with a headcount of approximately 53 employees. The name 'Institute For Biomedical Research' denotes its functional role: conducting biomedical and pharmaceutical research, most plausibly as an internal R&D site supporting Novartis's broader drug discovery and development operations. No further operational, scientific, or commercial specifics are documented in the available source material regarding therapeutic focus areas, modalities, or pipeline contribution.

Given its apparent status as an internal Novartis R&D unit, the institute's outputs would typically feed into the parent company's therapeutic pipeline through preclinical research, target validation, translational science, or related activities. However, the input data provides no information on research programs, technology platforms, intellectual property, scientific publications, or collaborations attributable to this site. No products, services, or partnerships are enumerated in the firmographic or supplementary records.

The source material is extremely thin and offers no detail on business model, revenue mechanics, funding sources, customer relationships, management, regulatory standing, or integration with Novartis's corporate structure. The bulk of the provided content is PubMed (US National Library of Medicine) homepage material unrelated to the institute. This data gap means the descriptive content above is limited to basic firmographic facts and inferences strictly bounded by the entity's name; any further operational characterization would exceed the evidentiary base and should be treated with caution.

Name

Novartis Institute For Biomedical Research

Website

https://pubmed.ncbi.nlm.nih.gov

Company type

Private

Headcount range

51–100 employees

Short description

The Novartis Institute For Biomedical Research is a 53-employee biomedical research entity in Emeryville, California, affiliated with global pharmaceutical company Novartis. It conducts drug discovery and biomedical research as part of Novartis's R&D operations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Biomedical research
• Pharmaceutical research
• Drug discovery
• Life sciences
• Clinical research

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

Based on the entity name alone, Novartis Institute For Biomedical Research appears to be a biomedical research organization conducting pharmaceutical research and drug discovery activities. The provided source data (PubMed website content) does not contain explicit information about the entity's specific product or service offerings. [Inferred from the firmographic entity name; no direct evidence in supplied sources] The provided source page is PubMed, a U.S. National Library of Medicine biomedical literature database, and contains no information about this entity.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• AbbVie Research & Development: AbbVie's R&D division is a major pharmaceutical research organization comparable to NIBR in biomedical research scope and therapeutic area coverage.
• AstraZeneca R&D: AstraZeneca's R&D division is a major pharmaceutical research organization with similar therapeutic breadth and biomedical research focus to NIBR.
• Roche Pharma Research (pRED): Roche's Pharma Research and Early Development division is a dedicated biomedical research organization within a major pharmaceutical company, structurally similar to NIBR's role within Novartis.
• Merck Research Laboratories: Merck's research laboratories conduct pharmaceutical R&D across multiple therapeutic areas, comparable to NIBR in biomedical research scope and pipeline development.
• Genentech Research: Genentech's research division is a major biotech research organization within the Roche group, comparable to NIBR as a dedicated biomedical research arm within a global pharmaceutical company.
• GSK Research: GSK's research division focuses on pharmaceutical and vaccine R&D, comparable to NIBR in biomedical research focus and global pharmaceutical context.
• Sanofi R&D: Sanofi's R&D division is a major pharmaceutical research organization with comparable biomedical research scope and therapeutic breadth to NIBR.
• Pfizer Research & Development: Pfizer's R&D division is one of the largest pharmaceutical research organizations globally, comparable to NIBR in biomedical research orientation and therapeutic area coverage.
• Eli Lilly Research Laboratories: Eli Lilly's research laboratories conduct pharmaceutical R&D across multiple therapeutic areas, comparable to NIBR in biomedical research orientation and scale.
• Bristol-Myers Squibb Research: Bristol-Myers Squibb's R&D division is a major pharmaceutical research organization comparable to NIBR in biomedical research focus and pipeline development.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks3 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/novartis-institute-for-biomedical-research

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novartis Institute For Biomedical Research